| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| MORGAN STANLEY | 12% | $192,768,956 | 50,200,249 | Morgan Stanley | 31 Mar 2025 | |||
| North Peak Capital Management, LLC | 9.5% | +86% | $40,594,316 | +$18,411,536 | 39,411,957 | +83% | North Peak Capital Management, LLC | 30 Sep 2025 |
| VANGUARD GROUP INC | 4.4% | -24% | $12,618,229 | -$4,112,087 | 18,321,808 | -25% | The Vanguard Group | 31 Dec 2025 |
| FMR LLC | 3.7% | -63% | $15,838,857 | -$24,084,688 | 15,377,531 | -60% | FMR LLC | 30 Sep 2025 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.6% | -47% | $57,549,684 | -$51,420,591 | 14,986,897 | -47% | Wellington Management Group LLP | 31 Mar 2025 |
| Capital World Investors | 2.6% | -76% | $9,333,531 | -$29,857,186 | 10,852,943 | -76% | Capital World Investors | 29 Aug 2025 |
| Capital International Investors | 2.4% | -60% | $22,060,815 | -$27,739,262 | 9,892,742 | -56% | Capital International Investors | 30 Jun 2025 |
As of 31 Dec 2025, 192 institutional investors reported holding 371,144,958 shares of agilon health, inc. - Common Stock (AGL). This represents 89% of the company’s total 415,460,499 outstanding shares.
The largest institutional shareholders of agilon health, inc. - Common Stock (AGL) together control 84% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Clayton, Dubilier & Rice, LLC | 24% | 100,000,000 | 0% | 12% | $69,000,000 |
| MORGAN STANLEY | 13% | 53,877,223 | -9.3% | 0% | $37,105,242 |
| North Peak Capital Management, LLC | 9.2% | 38,139,937 | +11% | 2.9% | $26,266,975 |
| BlackRock, Inc. | 5.4% | 22,615,061 | -6.5% | 0% | $15,574,993 |
| D. E. Shaw & Co., Inc. | 4.9% | 20,311,334 | +103% | 0.01% | $13,988,415 |
| GOLDMAN SACHS GROUP INC | 4.8% | 20,055,214 | +196% | 0% | $13,812,025 |
| VANGUARD GROUP INC | 4.4% | 18,321,808 | -25% | 0% | $12,623,725 |
| AQR CAPITAL MANAGEMENT LLC | 2.5% | 10,211,767 | +1347% | 0% | $7,032,843 |
| Capital World Investors | 2% | 8,364,227 | 0% | 0% | $5,760,443 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.9% | 8,019,002 | +31% | 0% | $5,522,687 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7% | 7,177,477 | +0.49% | 0% | $4,944,078 |
| CenterBook Partners LP | 1.7% | 7,021,522 | -39% | 0.24% | $4,835,722 |
| Rock Springs Capital Management LP | 1.6% | 6,500,000 | -6.7% | 0.23% | $4,476,550 |
| STATE STREET CORP | 1.5% | 6,318,625 | -18% | 0% | $4,351,637 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.97% | 4,037,979 | +30% | 0.01% | $2,780,956 |
| UBS Group AG | 0.82% | 3,395,366 | +251% | 0% | $2,339,407 |
| FMR LLC | 0.69% | 2,882,933 | -82% | 0% | $1,985,476 |
| RENAISSANCE TECHNOLOGIES LLC | 0.57% | 2,371,037 | +62% | 0% | $1,632,933 |
| NORTHERN TRUST CORP | 0.55% | 2,286,186 | -14% | 0% | $1,574,496 |
| GSA CAPITAL PARTNERS LLP | 0.49% | 2,044,795 | 0.12% | $1,408,000 | |
| Amundi | 0.47% | 1,969,309 | 0% | $1,356,263 | |
| CITADEL ADVISORS LLC | 0.3% | 1,240,086 | -68% | 0% | $854,047 |
| Numerai GP LLC | 0.3% | 1,228,071 | +207% | 0.1% | $845,772 |
| TWO SIGMA ADVISERS, LP | 0.27% | 1,114,200 | 0% | $767,350 | |
| TWO SIGMA INVESTMENTS, LP | 0.27% | 1,108,391 | 0% | $763,349 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 371,144,958 | $255,803,179 | -$10,884,646 | $0.69 | 192 |
| 2025 Q3 | 381,667,622 | $393,148,245 | -$40,920,709 | $1.03 | 188 |
| 2025 Q2 | 399,328,682 | $918,636,706 | -$2,996,581 | $2.30 | 204 |
| 2025 Q1 | 399,826,350 | $1,730,807,498 | -$76,575,360 | $4.33 | 198 |
| 2024 Q4 | 416,234,592 | $791,149,797 | -$48,593,665 | $1.90 | 183 |
| 2024 Q3 | 430,599,052 | $1,691,470,202 | -$113,061,378 | $3.93 | 208 |
| 2024 Q2 | 455,653,328 | $2,979,967,947 | +$79,546,138 | $6.54 | 201 |
| 2024 Q1 | 443,787,505 | $2,706,552,672 | -$123,526,322 | $6.10 | 196 |
| 2023 Q4 | 448,445,736 | $5,627,999,290 | -$86,646,980 | $12.55 | 191 |
| 2023 Q3 | 453,084,974 | $8,047,230,241 | +$191,740,226 | $17.76 | 182 |
| 2023 Q2 | 441,924,134 | $7,662,666,468 | -$98,821,035 | $17.34 | 185 |
| 2023 Q1 | 447,304,552 | $10,625,730,982 | +$380,606,408 | $23.75 | 201 |
| 2022 Q4 | 431,582,727 | $6,968,757,708 | +$108,690,436 | $16.14 | 168 |
| 2022 Q3 | 423,431,419 | $9,916,406,555 | +$176,516,049 | $23.42 | 171 |
| 2022 Q2 | 413,012,885 | $9,021,247,394 | +$291,140,328 | $21.83 | 142 |
| 2022 Q1 | 399,667,807 | $10,129,841,658 | +$205,624,833 | $25.35 | 117 |
| 2021 Q4 | 390,547,332 | $10,544,871,738 | +$1,563,624,581 | $27.00 | 125 |
| 2021 Q3 | 332,148,873 | $8,681,146,469 | +$10,635,889 | $26.21 | 99 |
| 2021 Q2 | 330,692,941 | $13,244,783,310 | +$13,244,729,185 | $40.57 | 92 |